Search Results - "VOLKIN, D. B"

Refine Results
  1. 1

    Enhancement of DNA vaccine potency using conventional aluminum adjuvants by Ulmer, J.B., DeWitt, C.M., Chastain, M., Friedman, A., Donnelly, J.J., McClements, W.L., Caulfield, M.J., Bohannon, K.E., Volkin, D.B., Evans, R.K.

    Published in Vaccine (20-08-1999)
    “…The immunogenicity and protective efficacy of DNA vaccines have been amply demonstrated in numerous animal models of infectious disease. However, the…”
    Get full text
    Journal Article
  2. 2

    Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies by Evans, R K, Xu, Z, Bohannon, K E, Wang, B, Bruner, M W, Volkin, D B

    Published in Journal of pharmaceutical sciences (01-01-2000)
    “…The stability of highly purified supercoiled plasmid DNA formulated in simple phosphate or Tris-buffered saline solutions has been characterized to establish…”
    Get more information
    Journal Article
  3. 3

    Thermal destruction processes in proteins involving cystine residues by Volkin, D.B., Klibanov, A.M.

    Published in The Journal of biological chemistry (05-03-1987)
    “…To ascertain the upper limit of protein thermostability and to evaluate the introduction of additional -S-S- bridges for the enhancement of protein…”
    Get full text
    Journal Article
  4. 4

    Nature of the interaction of heparin with acidic fibroblast growth factor by Mach, Henryk, Volkin, David B, Burke, Carl J, Middaugh, C. Russell, Linhardt, Robert J, Fromm, Jonathan R, Loganathan, Duraikkannu, Mattsson, Lars

    Published in Biochemistry (Easton) (25-05-1993)
    “…The binding of human acidic fibroblast growth factor (aFGF) to heparin has been analyzed by a variety of different approaches to better elucidate the nature of…”
    Get full text
    Journal Article
  5. 5

    Formulation, stability, and delivery of live attenuated vaccines for human use by Burke, C J, Hsu, T A, Volkin, D B

    “…The successful use of live attenuated viral and bacterial vaccines depends not only on the proper choice and delivery of the microorganisms, but also on…”
    Get more information
    Journal Article
  6. 6

    Degradative covalent reactions important to protein stability by VOLKIN, D. B, MACH, H, MIDDAUGH, C. R

    Published in Molecular biotechnology (01-10-1997)
    “…Commonly observed chemical modifications that occur in proteins during their in vitro purification, storage, and handling are discussed. Covalent modifications…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Nature of the interaction of growth factors with suramin by Middaugh, C. Russell, Mach, Henryk, Burke, Carl J, Volkin, David B, Dabora, Jonathan M, Tsai, P. K, Bruner, Mark W, Ryan, James A, Marfia, Kimberly E

    Published in Biochemistry (Easton) (22-09-1992)
    “…Suramin inhibits the binding of a variety of growth factors to their cell surface receptors. The direct interaction of suramin with acidic fibroblast growth…”
    Get full text
    Journal Article
  9. 9

    Physical stabilization of acidic fibroblast growth factor by polyanions by Volkin, D B, Tsai, P K, Dabora, J M, Gress, J O, Burke, C J, Linhardt, R J, Middaugh, C R

    Published in Archives of biochemistry and biophysics (01-01-1993)
    “…Acidic fibroblast growth factor (aFGF) is markedly stabilized by heparin. Partially due to the heterogeneity of heparin preparations, the nature of the aFGF…”
    Get more information
    Journal Article
  10. 10

    Formulation design of acidic fibroblast growth factor by TSAI, P. K, VOLKIN, D. B, DABORA, J. M, THOMPSON, K. C, BRUNER, M. W, GRESS, J. O, MATUSZEWSKA, B, KEOGAN, M, BONDI, J. V, MIDDAUGH, C. R

    Published in Pharmaceutical research (01-05-1993)
    “…The design of an aqueous formulation for acidic fibroblast growth factor (aFGF) requires an understanding of the type of compounds that can either directly or…”
    Get full text
    Journal Article
  11. 11

    Size and conformational stability of the hepatitis A virus used to prepare VAQTA, a highly purified inactivated vaccine by Volkin, D B, Burke, C J, Marfia, K E, Oswald, C B, Wolanski, B, Middaugh, C R

    Published in Journal of pharmaceutical sciences (01-06-1997)
    “…A variety of biophysical techniques have been employed to examine the size and conformational integrity of highly purified hepatitis A virus (HAV) in solution…”
    Get more information
    Journal Article
  12. 12

    Effect of polyanions on the unfolding of acidic fibroblast growth factor by Burke, Carl J, Volkin, David B, Mach, Henryk, Middaugh, C. Russell

    Published in Biochemistry (Easton) (29-06-1993)
    “…The urea-induced unfolding of acidic fibroblast growth factor (aFGF) in the presence and absence of various polyanions has been quantitatively examined by…”
    Get full text
    Journal Article
  13. 13

    Partially structured self-associating states of acidic fibroblast growth factor by Mach, Henryk, Ryan, James A, Burke, Carl J, Volkin, David B, Middaugh, C. Russell

    Published in Biochemistry (Easton) (03-08-1993)
    “…A combination of near- and far-UV circular dichroism, Fourier-transform infrared spectroscopy, tryptophan fluorescence, size-exclusion chromatography, and a…”
    Get full text
    Journal Article
  14. 14

    Bacteriophage T7 RNA polymerase and its active-site mutants. Kinetic, spectroscopic and calorimetric characterization by Osumi-Davis, P A, Sreerama, N, Volkin, D B, Middaugh, C R, Woody, R W, Woody, A Y

    Published in Journal of molecular biology (18-03-1994)
    “…It has been demonstrated that the amino acids Asp537, Asp812, Lys631, His811 and Tyr639 are involved in bacteriophage T7 RNA polymerase catalysis. In the…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Analysis of vaccine stability by Volkin, D B, Burke, C J, Sanyal, G, Middaugh, C R

    “…The complexity of vaccines creates a unique formulation challenge. Vaccines may consist of one or more types of antigenic component including live attenuated…”
    Get more information
    Journal Article
  17. 17

    Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q by Tenner, A J, Volkin, D B

    Published in Biochemical journal (15-01-1986)
    “…An enzyme-linked immunosorbent assay (e.l.i.s.a.) that is capable of quantifying C1q concentrations as low as 2 ng/ml and a sensitive haemolytic assay were…”
    Get full text
    Journal Article
  18. 18

    Size exclusion HPLC method for the determination of acidic fibroblast growth factor in viscous formulations by Bruner, Mark W., Goldstein, Joel, Russell Middaugh, C., Brooks, Marvin A., Volkin, David B.

    “…A size exclusion HPLC method has been developed to determine the protein concentration of pharmaceutical formulations of recombinant acidic fibroblast growth…”
    Get full text
    Journal Article
  19. 19

    Deamidation of polyanion-stabilized acidic fibroblast growth factor by Volkin, D B, Verticelli, A M, Bruner, M W, Marfia, K E, Tsai, P K, Sardana, M K, Middaugh, C R

    Published in Journal of pharmaceutical sciences (01-01-1995)
    “…The deamidation of polyanion-stabilized acidic fibroblast growth factor (aFGF; FGF-1) can be induced by prolonged storage under accelerated conditions of…”
    Get more information
    Journal Article
  20. 20